Clinical Trial: Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06800612) titled 'Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers' on Dec. 27, 2024.

Brief Summary: retrospective/prospective observational study. Objective of the study is to evaluate the effect of drugs in terms of objective responses, disease-free survival (DFS), progression-free survival (PFS), overall survival (OS), and side effects compared with registry studies in the medical therapy of breast and gynecologic cancers.

Study Start Date: March 22, 2024

Study Type: OBSERVATIONAL

Condition: Breast Cancer Early Stage Breast Cancer (Stage 1-3) Breast Cancer Metastatic Ovarian ...